CollPlant Biotechnologies Ltd. CLGN
NASDAQ
| 06/30/2026 | 12/31/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Net Income | -- | -- | 25.57% | -84.90% | |
| Total Depreciation and Amortization | -- | -- | -11.58% | -9.07% | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | -- | -- | -26.95% | -5.45% | |
| Change in Net Operating Assets | -- | -- | -99.71% | -150.52% | |
| Cash from Operations | -- | -- | -282.51% | -367.93% | |
| Capital Expenditure | -- | -- | 72.09% | 53.98% | |
| Sale of Property, Plant, and Equipment | -- | -- | -97.06% | -97.06% | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -- | 100.00% | 78.89% | |
| Cash from Investing | -- | -- | 78.14% | 57.46% | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | -- | -- | 1,278.67% | -100.00% | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | |
| Cash from Financing | -- | -- | 1,278.67% | -100.00% | |
| Foreign Exchange rate Adjustments | -- | -- | 179.55% | 91.82% | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -- | -- | -104.70% | -250.35% | |